These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2246970)

  • 1. Dose-response characteristics for glucose-stimulated insulin release in man and assessment of influence of glucose on arginine-stimulated insulin release.
    van Haeften TW; Boonstra E; Veneman TF; Gerich JE; van der Veen EA
    Metabolism; 1990 Dec; 39(12):1292-9. PubMed ID: 2246970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response characteristics for arginine-stimulated insulin secretion in man and influence of hyperglycemia.
    van Haeften TW; Voetberg GA; Gerich JE; van der Veen EA
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1059-64. PubMed ID: 2677037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased insulin secretory capacity and normal pancreatic B-cell glucose sensitivity in non-obese patients with NIDDM.
    Van Haeften TW; Van Maarschalkerweerd WW; Gerich JE; Van der Veen EA
    Eur J Clin Invest; 1991 Apr; 21(2):168-74. PubMed ID: 1905629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of gliclazide on glucose-stimulated insulin release in man.
    van Haeften TW; Veneman TF; Gerich JE; van der Veen EA
    Metabolism; 1991 Jul; 40(7):751-5. PubMed ID: 1870430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of lysine acetyl-salicylate on glucose and arginine stimulated insulin release in man.
    van Haeften TW; Veneman TF; van der Veen EA
    Horm Metab Res; 1991 Apr; 23(4):168-70. PubMed ID: 1908430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive stimulation of insulin secretion with arginine and glucose.
    Van Haeften TW; Van Faassen I; Van der Veen EA
    Diabetes Res; 1988 Dec; 9(4):187-91. PubMed ID: 3073905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinemia decreases second-phase but not first-phase arginine-induced insulin release in humans.
    Piatti PM; Pontiroli AE; Caumo A; Santambrogio G; Monti LD; Costa S; Garbetta F; Baruffaldi L; Cobelli C; Pozza G
    Diabetes; 1994 Sep; 43(9):1157-63. PubMed ID: 7915241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.
    Matthews DR; Boland O
    Metabolism; 1997 Dec; 46(12 Suppl 1):5-9. PubMed ID: 9439551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginine-induced insulin release in glucokinase-deficient subjects.
    Pueyo ME; Clement K; Vaxillaire M; Passa P; Froguel P; Robert JJ; Velho G
    Diabetes Care; 1994 Sep; 17(9):1015-21. PubMed ID: 7988299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man.
    Ghigo E; Maccario M; Arvat E; Valetto MR; Valente F; Nicolosi M; Mazza E; Martina V; Cocchi D; Camanni F
    Metabolism; 1992 Jan; 41(1):85-9. PubMed ID: 1371576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of galanin on glucose-, arginine-, or potassium-stimulated insulin release.
    Yoshimura T; Ishizuka J; Greeley GH; Thompson JC
    Am J Physiol; 1989 May; 256(5 Pt 1):E619-23. PubMed ID: 2470257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man.
    Ligtenberg JJ; Venker CE; Sluiter WJ; Reitsma WD; Van Haeften TW
    Eur J Clin Invest; 1997 Aug; 27(8):685-9. PubMed ID: 9279533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of acute hyperglycemia on insulin secretion in humans.
    Toschi E; Camastra S; Sironi AM; Masoni A; Gastaldelli A; Mari A; Ferrannini E; Natali A
    Diabetes; 2002 Feb; 51 Suppl 1():S130-3. PubMed ID: 11815471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans.
    Carpentier A; Giacca A; Lewis GF
    Diabetologia; 2001 Nov; 44(11):1989-97. PubMed ID: 11719829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ghrelin on insulin and glucagon secretion: a study of isolated pancreatic islets and intact mice.
    Salehi A; Dornonville de la Cour C; Håkanson R; Lundquist I
    Regul Pept; 2004 May; 118(3):143-50. PubMed ID: 15003830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta cell glucose stimulus-response curve in normal humans assessed by insulin and C-peptide secretion rates.
    Rudenski AS; Hosker JP; Burnett MA; Matthews DR; Turner RC
    Metabolism; 1988 Jun; 37(6):526-34. PubMed ID: 3287091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acute administration of gliclazide on the glucose sensitivity of pancreatic B-cells in healthy subjects.
    Veneman TF; van Haeften TW; van der Veen EA
    Clin Sci (Lond); 1991 Jul; 81(1):101-6. PubMed ID: 1649715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of arginine and glucose on the release of insulin in the sheep fetus.
    Fowden AL
    J Endocrinol; 1980 Apr; 85(1):121-9. PubMed ID: 6993600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor I inhibits glucose-stimulated insulin secretion but does not impair glucose metabolism in normal humans.
    Rennert NJ; Caprio S; Sherwin RS
    J Clin Endocrinol Metab; 1993 Mar; 76(3):804-6. PubMed ID: 8445040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic insulin release as the expression of combined inhibitory and potentiating effects of glucose.
    Nesher R; Cerasi E
    Endocrinology; 1987 Sep; 121(3):1017-24. PubMed ID: 3304974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.